EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism

Sarmed Al-Samerria iD, Sally Radovick

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119556 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sarmed Al-Samerria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Growth and Reproductive Development, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers, The State University …. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Human Growth Hormone. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institute for Health Care Management Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a growing public health problem worldwide, and GH and IGF-1 have been studied as potential therapeutic targets for managing this condition. This review article aims to provide a comprehensive view of the interplay between GH and IGF-1 and metabolism within the context of obesity. We conducted a systematic review of the literature that was published from 1993 to 2023, using MEDLINE, Embase, and Cochrane databases. We included studies that investigated the effects of GH and IGF-1 on adipose tissue metabolism, energy balance, and weight regulation in humans and animals. Our review highlights the physiological functions of GH and IGF-1 in adipose tissue metabolism, including lipolysis and adipogenesis. We also discuss the potential mechanisms underlying the effects of these hormones on energy balance, such as their influence on insulin sensitivity and appetite regulation. Additionally, we summarize the current evidence regarding the efficacy and safety of GH and IGF-1 as therapeutic targets for managing obesity, including in pharmacological interventions and hormone replacement therapy. Finally, we address the challenges and limitations of targeting GH and IGF-1 in obesity management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor IHuman Growth HormoneAnimalsHumansGrowth HormoneObesityAdipose TissueInsulin

Stichwörter der Autor:innen

body compositionenergy expendituregrowth hormone (gh)insulin-like growth factor 1 (igf-1)lipolysismetabolismobesity

Substanzen

Insulin-Like Growth Factor IGrowth HormoneInsulinHuman Growth Hormone

Autor:innen und Institutionen

  • Laboratory of Human Growth and Reproductive Development, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.

ORCID-Profile: Sarmed Al-Samerria

Förderung

  • NICHD NIH HHS
  • National Institute for Health Care Management Foundation

Zitieren

APA

Al-Samerria, S., & Radovick, S. (2023). Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119556

Vancouver

Al-Samerria S, Radovick S. Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119556

BibTeX
@article{AlSamerria2023,
  author = {Al-Samerria, Sarmed and Radovick, Sally},
  title = {Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119556}
}
Kostenlos starten →